In Summary, the novel PDE4 inhibitor, compound 2, exhibits antipruritic and anti-inflammatory effects against DNCB-induced AD in NC/Nga mice with low IC50 value (15 ± 0.4 nM) against PDE4B. Here, PDE4B is linked to Alzheimer disease.